Kalvista Pharmaceuticals, Inc.
KALV
Revenue
50.00M
▲46.18M▲1207.53%
48 Months ChangeAssets
275.99M
▲115.16M▲71.60%
3 Months ChangeLiabilities
1.93M
▼-45.00k▼-2.28%
3 Months ChangeFree Cash Flow
-40.24M
▼-13.51M▼-50.51%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-04
Form 8-K
ID: 0000950170-24-112904
2024-09-10
Form 8-K
ID: 0000950170-24-105182
2024-09-05
Form 8-K
ID: 0000950170-24-104032
2024-09-05
Form 10-Q
ID: 0000950170-24-103981
2024-07-23
Form 8-K
ID: 0000950170-24-085653
2024-07-11
Form 8-K
ID: 0000950170-24-082997
2024-04-22
Form 8-K
ID: 0000950170-24-046481
2024-03-11
Form 8-K
ID: 0000950170-24-029342
2024-03-11
Form 10-Q
ID: 0000950170-24-029314
2024-03-07
Form 8-K
ID: 0001193125-24-061344